Last reviewed · How we verify

NCT05471804: ZEMBRIN

Psychological Effects of 8 Weeks Supplementation With Sceletium Tortuosum Extract

Status unknown NA Last updated 25 July 2022
What this trial tests

NA trial testing Sceletium tortuosum in Cognitive Change in 120 participants. Status unknown.

Timeline
18 May 2022
Primary endpoint
1 November 2022
1 November 2022

Quick facts

Lead sponsorNorthumbria University
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposebasic science
Enrollment120
Start date18 May 2022
Primary completion1 November 2022
Estimated completion1 November 2022
Sites1 location across United Kingdom

Drugs / interventions tested

Conditions studied

Sponsor

Northumbria University

Who can join

Adults 30 to 50, any sex, with Cognitive Change or Stress, Psychological. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study employs a randomized controlled trial to test the cognitive enhancing and stress relieving potential of the product Zembrin® in healthy adults when consumed over an 8 week period.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cognitive Change

Currently open trials in the same condition.

Other Northumbria University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05471804.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing